We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
295
177 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
Active, not recruiting
17
5.8%
Completed
67
22.7%
Not yet recruiting
160
54.2%
Recruiting
47
15.9%
Unknown
4
1.4%
No approval data available
- India has announced the world's first clinical study to scientifically evaluate Ayurveda as an adjunct to standard Anti-Tuberculosis Treatment, marking a historic convergence of traditional medicine and modern biotechnology. - The landmark study will enroll 1,250 newly diagnosed TB patients across eight premier institutions, focusing on nutritional recovery, disease progression, quality of life improvements, and safety of integrative therapy. - India accounts for approximately 25% of the global TB burden but has achieved a 21% decline in incidence since 2015, with TB cases reduced to 187 per 100,000 population in 2024. - The collaborative initiative between the Department of Biotechnology and Ministry of Ayush will deploy advanced scientific tools including DEXA scans, MRI, immune profiling, and single-cell RNA sequencing to evaluate outcomes.
